Kits Eyecare (FRA:0P3) Total Stockholders Equity: €45.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0P3 Kits Eyecare Ltd FRA:0P3
79 GF Score
Price €9.60
GF Value €8.69
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Kits Eyecare Total Stockholders Equity?

Kits Eyecare FRA:0P3 +0.52% 79 Total Stockholders Equity is €45.0 Mil as of Jun. 2026. GuruFocus rates FRA:0P3 with a GF Score™ of 79/100 and a GF Value™ of €8.69 (Fairly Valued). The stock has 1 warning sign investors should review.

Kits Eyecare's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €45.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Kits Eyecare's Book Value per Share for the quarter that ended in Jun. 2026 was €1.33. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Kits Eyecare's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.07.

Kits Eyecare  (FRA:0P3) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Kits Eyecare's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(45.028-0)/33.936
=1.33

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Kits Eyecare's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.549 + 2.637) / 45.028
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kits Eyecare Total Stockholders Equity Related Terms

Kits Eyecare Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Kits Eyecare's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kits Eyecare Total Stockholders Equity Chart

Kits Eyecare Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 37.88 37.32 35.16 38.81 38.58

Kits Eyecare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.53 38.18 38.58 44.08 45.03
FRA:0P3
79GF Score
Kits Eyecare Ltd FRA:0P3
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €45.0 Mil mean?
Kits Eyecare (FRA:0P3) has a Total Stockholders Equity of €45.0 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Kits Eyecare and its competitors.
Is Kits Eyecare's Total Stockholders Equity too high?
Kits Eyecare's current Total Stockholders Equity is €45.0 Mil. Overall, Kits Eyecare has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's Total Stockholders Equity compare to CASY and WSM?
Kits Eyecare's Total Stockholders Equity of €45.0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Retail - Cyclical company?
A good Total Stockholders Equity depends on the Retail - Cyclical industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Kits Eyecare and its competitors. Kits Eyecare's current Total Stockholders Equity is €45.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (FRA:0P3) is currently considered Fairly Valued. The stock's GF Value™ is €8.69, compared to a current price of €9.60 — trading 10.5% above its estimated fair value. The current Total Stockholders Equity is €45.0 Mil. Kits Eyecare's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Kits Eyecare (FRA:0P3), the current Total Stockholders Equity is €45.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kits Eyecare (FRA:0P3) Overvalued in 2026?

Based on GuruFocus' analysis, Kits Eyecare stock appears to be overvalued. The current stock price of €9.60 is trading 10.5% above its estimated GF Value™ of €8.69. GuruFocus considers Kits Eyecare to be Fairly Valued.

Key valuation signals for FRA:0P3:

  • Total Stockholders Equity: €45.0 Mil
  • GF Value™: €8.69 vs. price of €9.60 (10.5% above fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the FRA:0P3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kits Eyecare Business Description

Other Exchanges KTYCF:USAKITS:Canada
Address 510 Seymour Street, Suite 1020, Vancouver, BC, CAN, V6B 3J5
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
79GF Score

Get the complete analysis for FRA:0P3

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.60
Price
€8.69
GF Value